|
|
|
|
|
|
by grasshopperpurp
3378 days ago
|
|
|
WHO is far richer, and WHO should pay for it? Are we fine with these companies spending 1/4 of their combined profits and marketing on R & D, as J&J does? At best, this is a remarkably inefficient way to drive innovation. The largest 10 pharmaceutical companies spent a combined $32.5B more on sales and marketing than R & D. No problem here? People are skipping dosing to stretch their meds further. Some people can't afford meds at all. |
|
|